Amy Stark to Risk Assessment
This is a "connection" page, showing publications Amy Stark has written about Risk Assessment.
Connection Strength
0.017
-
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients. Clin Pharmacol Ther. 2014 Jun; 95(6):644-52.
Score: 0.017